Innospec/$IOSP
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Innospec
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
- Ticker
- $IOSP
- Sector
- Materials
- Primary listing
- NASDAQ
- Employees
- 2,450
- Headquarters
- Englewood, United States
- Website
- innospec.com
Innospec Metrics
BasicAdvanced
$1.9B
13.92
$5.67
0.85
$1.79
2.33%
Price and volume
Market cap
$1.9B
Beta
0.85
52-week high
$102.00
52-week low
$65.51
Average daily volume
257K
Dividend rate
$1.79
Financial strength
Current ratio
2.945
Quick ratio
1.844
Long term debt to equity
0.024
Total debt to equity
0.034
Dividend payout ratio (TTM)
31.55%
Profitability
EBITDA (TTM)
197.9
Gross margin (TTM)
27.66%
Net profit margin (TTM)
7.49%
Operating margin (TTM)
8.49%
Effective tax rate (TTM)
19.26%
Revenue per employee (TTM)
$760,000
Management effectiveness
Return on assets (TTM)
5.44%
Return on equity (TTM)
10.44%
Valuation
Price to earnings (TTM)
13.916
Price to revenue (TTM)
1.04
Price to book
1.41
Price to tangible book (TTM)
2.13
Price to free cash flow (TTM)
57.476
Free cash flow yield (TTM)
1.74%
Free cash flow per share (TTM)
1.372
Dividend yield (TTM)
2.27%
Forward dividend yield
2.33%
Growth
Revenue change (TTM)
4.73%
Earnings per share change (TTM)
-11,869.80%
3-year revenue growth (CAGR)
-1.57%
10-year revenue growth (CAGR)
7.71%
3-year earnings per share growth (CAGR)
3.78%
10-year earnings per share growth (CAGR)
4.33%
3-year dividend per share growth (CAGR)
10.13%
10-year dividend per share growth (CAGR)
10.33%
What the Analysts think about Innospec
Analyst ratings (Buy, Hold, Sell) for Innospec stock.
Analyst projections of the future price of Innospec stock.
Bulls say / Bears say
Third-quarter revenue rose 7% year on year, and adjusted EBITDA increased to $51.4 million from $44.2 million. All three businesses contributed to higher operating income, showing broad-based improvement. (Innospec)
Performance Chemicals operating income climbed 84% and its gross margin improved by 3.7 percentage points in the third quarter. Planned North Carolina plant upgrades are expected to lift capacity and yields, creating scope for further growth as utilisation and new-product sales build. (Innospec)
The expanded drag-reducing-agent business is driving Oilfield Services growth: third-quarter revenue rose 13% and operating income rose 40%. Innospec also reported more than $250 million of net cash, no debt and a 9% increase in its annual dividend, giving it room to invest and return cash to shareholders. (Innospec)
Performance Chemicals’ third-quarter volumes fell 5%, with weaker demand for personal-care products and supply constraints weighing on some regions. Revenue growth relied on higher prices and product mix rather than greater volumes, which may limit the durability of the recovery. (StreetInsider)
Oilfield Services still faces delays in its legacy Middle East business and elevated raw-material costs. Its third-quarter gross margin fell 1.8 percentage points year on year, despite higher sales and operating income. (Innospec)
Cash conversion is a concern: third-quarter operating cash flow was $17.4 million against $15.6 million of capital spending. Management said working capital had increased by about $80 million since the start of the year and acknowledged that inventory was higher than needed. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2026.
Innospec Financial Performance
Revenues and expenses
Innospec Earnings Performance
Company profitability
Upcoming events
Innospec News
AllArticlesVideos
Funds containing Innospec
Fund name | Fund size | $IOSP weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $2.5B | 0.11% |
iShares S&P Small Cap 600£ISP6 | $2.5B | 0.11% |
SPDR Russell 2000 US Small Cap€R2US | $4.7B | 0.07% |
SPDR Russell 2000 US Small Cap£R2SC | $4.7B | 0.07% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.04% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
